Ikapharmindo Putramas Tbk. (IKPM) — Working Capital to Net Assets Ratio
Ikapharmindo Putramas Tbk. (IKPM) has a Working Capital to Net Assets ratio of 45.5% as of June 2025. Working capital of Rp107.86 Billion (current assets of Rp320.79 Billion minus current liabilities of Rp212.93 Billion) is measured against net assets of Rp236.96 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Ikapharmindo Putramas Tbk. to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ikapharmindo Putramas Tbk. Working Capital to Net Assets (2022–2024)
This chart shows how Ikapharmindo Putramas Tbk.'s Working Capital to Net Assets ratio has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the ratio stands at 45.5%, reflecting working capital of Rp107.86 Billion against net assets of Rp236.96 Billion IDR. See IKPM days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Ikapharmindo Putramas Tbk. (2022–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ikapharmindo Putramas Tbk. from 2022 to 2024, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see IKPM stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (IDR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 47.3% | Rp116.45 Billion | Rp246.12 Billion | Rp337.20 Billion | Rp220.76 Billion | ▲ +1.6 pp |
| 2023 | 45.7% | Rp111.91 Billion | Rp244.71 Billion | Rp308.08 Billion | Rp196.17 Billion | ▲ +3.1 pp |
| 2022 | 42.6% | Rp75.34 Billion | Rp176.70 Billion | Rp268.80 Billion | Rp193.46 Billion | — |